IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

STACCHIOTTI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.519
NA - Nord America 4.530
AS - Asia 3.997
SA - Sud America 373
AF - Africa 145
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.361
DE - Germania 2.151
CN - Cina 1.251
SG - Singapore 1.058
GB - Regno Unito 888
IT - Italia 749
HK - Hong Kong 434
SE - Svezia 319
BR - Brasile 267
VN - Vietnam 254
BD - Bangladesh 247
RU - Federazione Russa 228
IN - India 225
FR - Francia 204
NL - Olanda 191
ES - Italia 166
FI - Finlandia 150
JP - Giappone 115
IE - Irlanda 108
CA - Canada 101
ID - Indonesia 82
KR - Corea 56
TR - Turchia 52
BE - Belgio 50
DK - Danimarca 48
CI - Costa d'Avorio 47
AT - Austria 40
CH - Svizzera 37
AR - Argentina 36
MX - Messico 36
PL - Polonia 34
TW - Taiwan 34
PH - Filippine 31
ZA - Sudafrica 31
UA - Ucraina 27
PK - Pakistan 26
AU - Australia 25
IQ - Iraq 25
PT - Portogallo 24
GR - Grecia 22
SI - Slovenia 21
CO - Colombia 19
UG - Uganda 19
IL - Israele 17
PE - Perù 16
SA - Arabia Saudita 15
CL - Cile 14
NO - Norvegia 13
RO - Romania 13
UZ - Uzbekistan 13
EG - Egitto 12
EC - Ecuador 10
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
MY - Malesia 7
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
NG - Nigeria 5
TN - Tunisia 5
VE - Venezuela 5
AL - Albania 4
BG - Bulgaria 4
NP - Nepal 4
ZW - Zimbabwe 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MA - Marocco 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
QA - Qatar 3
TZ - Tanzania 3
AM - Armenia 2
AP - ???statistics.table.value.countryCode.AP??? 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LT - Lituania 2
RS - Serbia 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
Totale 14.576
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.915
Southend 746
Singapore 630
Ashburn 493
Hong Kong 365
Chandler 345
Fairfield 327
San Jose 247
Milan 199
Beijing 198
Houston 176
Woodbridge 149
Seattle 142
Council Bluffs 138
Redwood City 135
Helsinki 126
Wilmington 126
Santa Clara 112
Los Angeles 107
Dublin 105
Ann Arbor 104
Cambridge 100
Dearborn 96
Princeton 95
Bengaluru 91
Dallas 91
New York 90
Ho Chi Minh City 87
Shanghai 74
Nanjing 71
Guangzhou 68
Jakarta 68
Moscow 62
Hanoi 61
Phoenix 61
Tokyo 57
Lauterbourg 56
Abidjan 47
Madrid 45
Buffalo 43
Columbus 43
Des Moines 43
Rome 43
Boardman 39
The Dalles 39
Hefei 36
Toronto 35
Munich 34
São Paulo 33
Central District 32
Jinan 31
Seoul 30
London 29
Tianjin 29
Cangzhou 28
Istanbul 28
Bologna 27
Chicago 26
Nuremberg 26
Taipei 26
San Francisco 23
Atlanta 22
Hangzhou 22
Nanchang 22
Shenzhen 22
Barcelona 21
Shenyang 21
Changsha 20
Mumbai 20
Amsterdam 19
Lubbock 19
Washington 19
San Diego 18
Turin 18
Brussels 17
Fuzhou 17
Ljubljana 16
Naples 16
Paris 16
Kampala 15
Ottawa 15
Athens 14
Johannesburg 14
Boston 13
Delhi 13
Hyderabad 13
Montreal 13
Turku 13
Vienna 13
Wuhan 13
Buenos Aires 12
Chengdu 12
Duncan 12
Hebei 12
Rho 12
Berlin 11
Silver Spring 11
Verona 11
Warsaw 11
Zhengzhou 11
Totale 9.537
Salva come PNG Salva come JPEG
Nome #
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 846
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 719
High-grade soft-tissue sarcomas: Tumor response assessment - Pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria 652
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 543
Community-based rehabilitation program for cerebral PALSY (CP) children in North Uganda 454
Primary extremity soft tissue sarcomas: Outcome improvement over time at a single institution 377
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience 356
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 333
Response to sunitinib malate in advanced alveolar soft part sarcoma 318
Best practices for the management of local-regional recurrent chordoma : a position paper by the Chordoma Global Consensus Group 303
Solitary fibrous tumour presenting with a single bone metastasis : report of six cases and literature review 301
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study 284
Imatinib mesylate in chordoma 275
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts 271
High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma 270
Role of chemotherapy, VEGFR inhibitors and mTOR Inhibitors in advanced Perivascular Epithelioid Cell Tumours (PEComas) 266
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study 260
Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients 251
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue 246
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors : A Multicenter, European Retrospective Case Series Analysis 243
Radiation-induced sarcoma of the head and neck: A review of the literature 242
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 240
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 239
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 236
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients—A propensity score analysis 235
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature 225
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas 224
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma : revisiting the results of the EORTC-STBSG 62931 randomised trial 213
Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib 213
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS) : long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 212
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study 210
Clinical prognostic factors in advanced epithelioid haemangioendothelioma : a retrospective case series analysis within the Italian Rare Cancers Network 207
Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: A case series analysis and literature review 206
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 203
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma : a multi-institutional case series 203
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour 202
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient [3] 196
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 195
Pazopanib for treatment of typical solitary fibrous tumours : a multicentre, single-arm, phase 2 trial 195
Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor : a case report and literature review 194
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation 191
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres 190
High-grade sarcomatous overgrowth in solitary fibrous tumors : a clinicopathologic study of 10 cases 185
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study 172
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib 171
Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients 153
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial 151
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study 150
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ 146
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial 144
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature 141
Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysis 136
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 132
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect? 131
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair 120
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas : Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups 111
Neoadjuvant treatment: A novel standard? 104
A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis 100
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group 93
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG) 80
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial 61
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial 57
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group 51
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity 44
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression 41
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review 40
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis 36
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall 31
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study 20
null 12
null 3
Totale 15.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 0 118 71
2021/2022820 70 92 49 46 61 38 55 47 59 64 54 185
2022/20231.128 133 114 102 133 121 153 42 69 143 24 71 23
2023/20242.134 45 62 49 64 203 93 319 284 139 269 296 311
2024/20252.429 261 266 198 248 155 112 79 174 108 203 224 401
2025/20264.382 409 214 282 273 345 347 688 257 567 315 685 0
Totale 15.055